C. Huggins, L. Grand, and F. Brillantes, Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its Suppression, Nature, vol.1, issue.4760, pp.189-204, 1961.
DOI : 10.1038/189204a0

J. Russo, I. Tav, and I. Russo, Differenciation of the mammary gland and susceptibility to carcinogenesis, Breast Cancer Res Treat, vol.23, pp.5-73, 1982.

J. Russo, I. Tait, and I. Russo, Susceptibility of the mammary gland to carcinogenesis III. The cell of origin of rat mammary carcinogens

F. Daniel and N. Jovco, DNA adduct formation by 7,12- dimethylbenz[a]anthracene and its noncarcinogenic 2-fluoro analog in the female Sprague-Dawley rats, Am J Pathol J Natl Cancer Inst, vol.1135, issue.70, pp.50-66, 1983.

T. Dao, The role of ovarian hormones in initiating the induction of mammary cancer in rats by polynuclear hydrocarbons, Cancer Res, vol.22, pp.975-981, 1962.

B. Kerdelhué, E. Abed, A. Kerdelhué, B. Castanier, M. Scholler et al., Inhibition of preovulatory gonadotropin secretion and stimulation of prolactin secretion by 7,12- dimethylbenz[a]anthracene in Sprague-Dawley rats Stimulation of estradiol-17 secretion by 7,12-dimethylbenz[a]anthracene during mammary tumor induction in Sprague-Dawley rats, Cancer Res J Steroids Biochem, vol.39, issue.26, pp.4700-4705, 1969.

M. Jakubowski, V. Lenoir, and M. Jimenez-linan, 12- Dimethylbenz[a]anthracene on Hypothalamic Gonadotropin- Releasing Hormone and Its Pituitary Receptor Gene Expression, during the promotion stage, in Female Sprague-Dawley Rats In vitro LHRH release . correlation with the LH surge and alteration by a mammary carcinogen Long-term dysregulation of circadian and 17ß estradiol ? induced LH,prolactin and corticosterone secretion after dimethylbenz (a) anthracene administration in the Sprague-Dawley female rat Long term inhibition by Estradiol or Progesterone of Melatonin secretion after administration of a mammary carcinogen ,the dimethyl benz (a) anthracene,in Sprague-Dawley female rat ; inhibitory effect of Melatonin on mammary carcinogenesis, Breast Cancer Res Treat Peptides Breast Cancer Res Treat Breast Cancer Res Treat, vol.7101112, issue.79, pp.23-29, 1981.

R. Reiter, The pineal gland and its hormones in the control of reproduction in mammals, Endocr Rev, vol.113, pp.109-131, 1980.

J. I. Vanececk, D. Blask, S. Hill, K. Orstead, J. Massa et al., 12 DMBA induced mammary tumorigenesis Melatonin Inhibition of Cancer Growth in vivo Involves Suppression of Tumor Fatty Acid metabolism via Melatonin Receptor-mediated Signal Transduction Events Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium Melatonin blocks the activation of estrogen receptor for DNA binding Modulation of Estrogen Receptor mRNA Expression by Melatonin in MCF-7 Human Breast Cancer Cells Melatonin increases oestrogen receptor binding activity of human breast cancer cells Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz [a] anthracene in the female Sprague-Dawley rat Tamoxifen for prevention of breast cancer : Report of the National Surgical Adjuvant Breast and Bowel project P-1 Study Kinetic study of melatonin release from rat pineal glands using a perifusion technique Seasonal variations in the daily rhythm of pineal gland and/or circulating melatonin and 5-methoxytrytophol concentrations in the European hamster, Cricetus cricetus Neuroendocrine integrative mechanism in mammalian pineal gland : effects of steroid and adenohypophysial hormones on melatonin synthesis in vitro Melatonin secretion from organ-cultured pineal glands of rats : modulation by gonadectomy and gonadotropin-releasing hormone agonist administration, Rev Reprod J Neural Transm Cancer Res Cancer Res J Pineal Res FASEB J Mol Endocrinol. Nature Breast Cancer Res J Natl Cancer Inst J Pineal Res Gen Comp Endocrinol J Steroid Biochem Eur J Endocrinol, vol.4171820222324, issue.142, pp.67-72, 1983.

F. Monjir, R. Bordon, C. Santano, P. Abreu, G. Hernandez et al., Ovarian steroids blocks the isoproterenol-induced elevation of pineal melatonin production in the femele rat, Neurosci Lett, vol.119, pp.12-14, 1990.

D. Cardinali, Nuclear Receptor Estrogen Complex in the Pineal Gland. Modulation by Sympathetic Nerves, Neuroendocrinology, vol.24, issue.5-6, pp.333-346, 1977.
DOI : 10.1159/000122720

R. Alonso, P. Abreu, and N. Fajardo, Ovarian hormones regulate alpha 1 and beta-adrenoceptor interactions in female rat pinealocytes Pineal melatonin synthesis and release are not altered throughout the estrous cycle in female rats, Neuroreport J Pineal Res, vol.630, issue.34, pp.345-348, 1995.

Y. Okatani, N. Morioko, A. Wakatsuki, S. Chaidarun, J. Alexander et al., Changes in nocturnal secretion in perimenopausal women: correlation with endogenous estrogen concentrations A Tumor-Specific Truncated Estrogen Receptor Splice Variant Enhances Estrogen-Stimulated Gene Expression(a)anthracene DNA Adducts Formed in Rat Mammary Gland, J Pineal Res Mol Endocrinol Chem Res Toxicol, vol.283234, issue.10, pp.111-118, 1997.

R. Garner, L. Tamarkin, M. Cohen, R. D. Reicher, C. Lippman et al., The role of DNA adducts in chemical carcinogenesis Melatonin inhibition and pinealectomy enhancement of 7,12- dimethyl-benz(a)anthracene-induced mammary tumors in the rat Suppressive effect by melatonin on different phases of 9,10-dimethyl-1,2-benzanthracene (DMBA)induced rat mammary gland carcinogenesis(a)anthracene on pineal melatonin biosynthesis, secretion and peripheral metabolism Decreased nocturnal plama melatonin peak in patients with estrogen receptor positive breast cancer Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism, Mutation Res Cancer Res Anti-Cancer Drugs Neuroendocrinology Science Cancer, vol.402383940, issue.67, pp.67-75, 1981.

S. Wilson, D. Blask, and A. Lemus-wilson, Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro., The Journal of Clinical Endocrinology & Metabolism, vol.75, issue.2, pp.669-670, 1992.
DOI : 10.1210/jcem.75.2.1639964